UNQ Holdings Limited (2177) AI Stock Analysis

• Market Cap: HK$436.30M
• Dividend Yield: 15.24%
• Average Volume (3M): 54.97K
• Price to Earnings (P/E): 16.7
• Beta (1Y): 0.05
• Revenue Growth: -9.26%
• EPS Growth: 435.33%
• Country: HK
• Employees: 217
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 0.07
• Shares Outstanding: 165,894,700
• 10 Day Avg. Volume: 78,620
• 30 Day Avg. Volume: 54,966
• PEG Ratio: -0.02
• Price to Book (P/B): 0.30
• Price to Sales (P/S): 0.16
• P/FCF Ratio: 1.27
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: HK$3.00 ▲(4.17% Upside)

The overall stock score of 64 reflects a mix of strengths and challenges. The most significant factor is the strong technical momentum, although overbought signals suggest caution. Financial performance is a concern due to declining revenues and profitability issues, but positive cash flow provides some stability. The high dividend yield enhances the stock's appeal, despite valuation being fair.

Positive Factors

Diversified healthcare business model

Operating across biotech, medical devices and health services creates multiple, complementary revenue streams (product sales, licensing, partnerships). This diversification reduces concentration risk and supports resilience and strategic optionality for 2-6+ months of execution and deal-making.

Positive operating and free cash flow

Recent positive operating and free cash flow provide durable internal funding for R&D, product commercialization and partnerships without immediate reliance on external financing. Reliable cash generation supports operational continuity and strategic investments over medium term.

Reduced leverage

Lower debt relative to equity improves financial flexibility, reduces interest burden and increases capacity to finance development or absorb shocks. Reduced leverage strengthens solvency and supports longer-term investment in innovation and commercialization.

Negative Factors

Declining revenue trend

Sustained revenue declines suggest weakening market adoption or competitive pressure. Falling top-line restricts reinvestment capacity, forces tougher allocation decisions for R&D and commercialization, and makes sustaining long-term growth targets more challenging without strategic inflection.

Profitability and margin weakness

Compressed gross margins and episodic negative operating profitability undermine ability to fund expansion internally. Persistent margin weakness increases sensitivity to cost shocks and limits returns from new product investments, pressuring long-term sustainability unless margins recover.

Unstable equity position and negative ROE

Declining shareholders' equity and negative ROE signal recurring losses that erode capital cushions. This weakens the balance sheet, may constrain access to new capital on attractive terms, and increases execution risk for multi‑period commercialization plans.

UNQ Holdings Limited Business Overview & Revenue Model

Company Description

UNQ Holdings Limited provides brand e-commerce retail and wholesale solutions in the People's Republic of China. It offers personal care products for adults, personal care products for babies, beauty products, health products, and household necessities. The company was incorporated in 2019 and is headquartered in Shanghai, China.

How the Company Makes Money

UNQ Holdings Limited generates revenue through multiple streams, primarily from the sale of its healthcare products, which include proprietary medical devices and biotechnology solutions. The company also earns income from licensing agreements and partnerships with other entities in the healthcare sector, allowing it to expand its market reach and share in the profits from collaborative projects. Additionally, UNQ Holdings may derive financial benefits from research grants and investments in innovative healthcare startups, contributing to its overall earnings and strategic growth.

UNQ Holdings Limited Financial Statement Overview

Summary

UNQ Holdings Limited faces challenges in revenue growth and profitability, with declining revenues and fluctuating net income. The balance sheet shows reduced leverage but instability in equity. Cash flow is a relative strength, with positive operating and free cash flow, though inconsistencies suggest room for improvement.

Income Statement

The income statement shows a declining revenue trend over the past few years, with a significant drop from 2020 to 2024. Gross profit margin has decreased, and net income has fluctuated, turning negative in some years. The company has struggled with profitability, as evidenced by negative EBIT and EBITDA margins in recent years, although there was a slight recovery in 2024.

Balance Sheet

The balance sheet reflects a moderate financial position with a declining debt-to-equity ratio, indicating reduced leverage. However, the equity ratio has been unstable, and stockholders' equity has decreased over time. The return on equity has been negative in several years, highlighting profitability challenges.

Cash Flow

Cash flow analysis reveals some strengths, with positive operating cash flow and free cash flow in recent years. However, the free cash flow growth rate has been inconsistent, and the company has experienced negative operating cash flow in earlier years, indicating potential cash management issues.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.32B	1.35B	1.74B	2.38B	3.03B	2.80B
Gross Profit	421.45M	404.69M	456.65M	569.16M	900.81M	888.11M
EBITDA	26.02M	29.55M	2.80M	-103.11M	90.18M	81.77M
Net Income	24.67M	37.89M	-18.22M	-117.92M	30.48M	-1.09M
Balance Sheet
Total Assets	1.18B	1.19B	1.16B	1.77B	2.03B	1.79B
Cash, Cash Equivalents and Short-Term Investments	364.72M	451.27M	357.22M	417.64M	447.08M	252.33M
Total Debt	227.47M	204.47M	232.05M	452.10M	596.86M	647.65M
Total Liabilities	440.71M	469.48M	430.09M	1.00B	1.14B	1.18B
Stockholders Equity	736.84M	719.47M	726.28M	762.97M	892.60M	618.73M
Cash Flow
Free Cash Flow	-6.67M	172.19M	142.75M	259.68M	-129.04M	-378.04M
Operating Cash Flow	-6.64M	172.19M	143.75M	260.03M	-124.75M	-368.42M
Investing Cash Flow	8.08M	-78.00K	-29.66M	-80.87M	60.70M	35.92M
Financing Cash Flow	-1.85M	-71.36M	-193.85M	-203.12M	254.74M	64.22M

UNQ Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2.88
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2177, the sentiment is Negative. The current price of 2.88 is above the 20-day moving average (MA) of 2.68, above the 50-day MA of 2.88, and above the 200-day MA of 2.66, indicating a bearish trend. The MACD of -0.08 indicates Negative momentum. The RSI at 40.18 is Neutral, neither overbought nor oversold. The STOCH value of 53.87 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:2177.

UNQ Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3828	77 Outperform	HK$714.26M	4.93	10.86%	10.87%	6.86%	18.44%
1925	74 Outperform	HK$473.90M	4.77	17.17%	8.33%	21.99%	11.36%
2177	64 Neutral	HK$436.30M	16.69	3.32%	15.24%	-9.26%	435.33%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
3332	62 Neutral	HK$648.05M	21.39	3.92%	―	-0.92%	-71.88%
2023	58 Neutral	HK$368.85M	6.48	10.92%	―	11.10%	-4.38%
2138	55 Neutral	HK$722.98M	-3.77	-10.08%	1.72%	-3.49%	-1567.01%

UNQ Holdings Limited Corporate Events

UNQ Holdings Completes 90% Acquisition of Japanese Company One Two Co., Ltd.

UNQ Holdings Limited has completed the acquisition of approximately 90% of the issued shares of Japan-based One Two Co., Ltd., after all conditions under the share purchase agreement were satisfied on 5 January 2026. Following completion, One Two Co., Ltd. has become an indirect non-wholly owned subsidiary of UNQ Holdings, and its financial results will now be consolidated into the group’s accounts, signaling a deepened presence in the Japanese market and a likely expansion of the company’s operational and earnings base.

The most recent analyst rating on (HK:2177) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on UNQ Holdings Limited stock, see the HK:2177 Stock Forecast page.

UNQ Holdings Shareholders Approve 2026 Products Procurement Framework Agreement

UNQ Holdings Limited announced that shareholders overwhelmingly approved, by poll, the 2026 Products Procurement Framework Agreement and its proposed annual caps at an extraordinary general meeting held in Shanghai on 24 December 2025, with 100% of votes cast in favour and no votes against. The approval, passed as ordinary resolutions after the major shareholder TCI abstained in accordance with listing rules, authorizes the board to implement and, if necessary, amend the framework agreement, clearing a key procedural hurdle for the company’s planned procurement activities in 2026 and reinforcing compliance with corporate governance and regulatory requirements.

The most recent analyst rating on (HK:2177) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on UNQ Holdings Limited stock, see the HK:2177 Stock Forecast page.

UNQ Holdings Acquires Majority Stake in Japanese Company

UNQ Holdings Limited has announced a significant acquisition involving the purchase of approximately 90% of the shares of a Japanese company for JPY2,701,000,000 (around HK$135,050,000). This acquisition will result in the Japanese company becoming an indirect non-wholly owned subsidiary of UNQ Holdings, with its financial results consolidated into UNQ’s financial statements. The transaction is classified as a discloseable transaction under Hong Kong’s Listing Rules, indicating its importance but not requiring shareholder approval. The completion of this acquisition is contingent upon certain conditions being met, and stakeholders are advised to exercise caution.

The most recent analyst rating on (HK:2177) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on UNQ Holdings Limited stock, see the HK:2177 Stock Forecast page.

UNQ Holdings Limited Announces Extraordinary General Meeting for Strategic Approvals

UNQ Holdings Limited, a company incorporated in the Cayman Islands, has announced an extraordinary general meeting scheduled for December 24, 2025, in Shanghai, China. The meeting will focus on approving the 2026 Products Procurement Framework Agreement, which outlines future transactions and proposed annual caps. This development is significant for stakeholders as it involves strategic decisions that could impact the company’s operations and market positioning.

The most recent analyst rating on (HK:2177) stock is a Hold with a HK$2.50 price target. To see the full list of analyst forecasts on UNQ Holdings Limited stock, see the HK:2177 Stock Forecast page.